-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical network August 20th, August 20th, the third batch of national volume procurement opened tenders! At present, we are most concerned about how to report a cost-effective bid price, both to win the bid, but also to minimize the price reduction.
in the highly competitive situation, this idea is not necessarily too idealistic, but the systematic analysis of the previous three national volume procurement of the results will still be instructive.
to date, the national level has carried out the "4 plus 7", "4 plus 7" expansion and the second batch of a total of 3 centralized procurement of drugs (the "first 3 national harvests" below).
the author previously published the "opening of tenders in the immediate!" The third batch of volume procurement, 8 charts all-round analysis and "third batch of volume procurement, 6 charts depth analysis" two articles, from different angles of the third batch of national procurement analysis, this paper will stand in the bidding main pharmaceutical enterprises, the first 3 national procurement of selected varieties, procurement volume and procurement amount to do a systematic analysis, in order to provide some reference for tomorrow's quotation.
statistics for this article are based on enterprise groups.
the largest number of selected varieties huahai in the first three national harvests a total of 185 varieties of the election, involving 89 enterprises (groups) (have gone heavy).
, 25 of the "4 plus 7" were selected, 60 were selected in the "4 plus 7" expansion, and 100 were selected in the second batch.
many enterprises in the same variety in the "4 plus 7" and "4 plus 7" expansion are selected, but in order to facilitate analysis, the "4 plus 7" and "4 plus 7" expansion of the selected varieties are calculated once.
Comprehensive first 3 national mining, the most selected varieties are Zhejiang Huahai, a total of 15 varieties selected, China Biopharmaceuticals and Shandong Qilu each selected 9, Yangzijiang and Koren each selected 7, Zhejiang Jingxin and Shanghai Fosun each 6.
the first six enterprises in the number of selected varieties accounted for 32% of the total number of selected varieties in the country, it can be seen that the official promotion of the new pattern of medicine has begun to emerge.
On November 29, 2019, the State Council's Leading Group on Deepening Medical Reform issued a number of policy measures on further deepening the reform of the medical and health system with centralized procurement and use of drugs as a breakthrough: "Accelerate the formation of a pattern of drug production and circulation with large backbone enterprises as the main body and small and medium-sized enterprises as the supplement."
" Huahai selected the largest number of varieties, because the country's priority for the production of the same production line in europe and the United States mainstream countries listed and sold products declaration consistency evaluation, and the advantages of the internationalization of Huahai Pharmaceuticals has been fully reflected: "4 plus 7" start-up, it has 17 Specifications, 11 varieties through the consistency evaluation, far more than other pharmaceutical companies, and its low cost, of which 6 varieties of over-evaluation fee of less than 3 million yuan, the minimum of only 1.59 million yuan, with other enterprises moved over 10 million over-evaluation fees, quite advantageous.
addition, Huahai raw material advantages are obvious, than no raw materials preparation enterprises have a lot of profit space.
, Huahai in the domestic preparation market or new recruits, can be described as "barefoot" enterprises, the price is not pressured.
also reminded the relevant pharmaceutical companies, in the context of the normal procurement of raw materials must be carried out in the strategic integration.
, zhejiang Jingxin, which is very similar to the situation in Huahai, also achieved the third-among the best results in the number of selected varieties, and these two enterprises also laid the foundation for Zhejiang's brilliant achievements in the "4 plus 7" collection.
In the "4 plus 7" collection, the number of selected varieties in Zhejiang (Huahai 6, Beijing New 3) accounted for 36% of the country;
the largest purchase volume of Bayer's first three national picks, the largest number of selected varieties purchased by The German Bayer, a total of 1.27 billion pieces, it only by the second batch of the winning bid of Akapo sugar is firmly at the top of the list, when the company with a price reduction of up to 78% also became the second batch of the largest explosion point.
Akapo sugar also created a procurement volume runner-up Sichuan green leaf, the first five pharmaceutical companies (Bayer, Green Leaf, Huahai, Jingxin, Koren) procurement volume accounted for 30% of the total procurement volume of the first three countries.
the highest procurement volume Yangzijiang procurement volume is yangzijiang, the first three countries to pick its total procurement of nearly 1 billion yuan, one of which accounted for 12% of the total procurement of the first three national procurement.
In the environment that has competed for a few cents of the drug, it is not easy to have this performance, mainly due to the company's first over-rated and in the "4 plus 7" and "4 plus 7" expansion in the continuous bid of hydrochloric acid right meetomide injection (0.2mg/2) ml), compared to oral preparations in which the unit price is high (133 yuan / branch), the price of 1 hydrochloric acid right meetamide injection is equivalent to the price of 4000 tablets of acetaminophen tablets 0.5g (the second batch of the selected price is 0.033 yuan / tablet).
The other selected purchases were 560 million yuan in Huahai, 500 million yuan in China's biopharmaceuticals (including Zheng daqing and Beijing Ted), and the fourth was Shenzhen Xinlitai, which accounted for 23% of the total purchase value of "4 plus 7" by relying on a product of hydrochloride chlorpyrene tablets, which won the "4 plus 7".
the top four pharmaceutical companies accounted for 30 per cent of the total procurement of the first three national procurements.
As shown in Figure 4, because of the "4 plus 7" and the expansion of the selection, Yangzijiang's hydrochloric acid right meetumide injection sales rose sharply, as barefoot, quickly seized the market share of the unsealed enterprises.
profit is the most abundant Yangzijiang profit is more difficult to statistics, a listing report is not subdivided, and two Yangzijiang and so on because of the unlisted without disclosure, but through analysis can still be inferred.
as shown in figure 3, the largest purchase volume in the first three countries was Yangtze River, which was almost equal to the second and third places in total.
And for Yangzijiang to contribute to the procurement volume is mainly hydrochloric acid right meetumidine injection, because it is the first over-rated, so the "4 plus 7" election only reduced by 12% that is the winning bid, is the third-lower decline, only than the cephalosporine tablets (times, down 11.5%) and monterestone dispersion (Hainan first sound, down 6.9%) a larger decline.
relative to the "4 plus 7" when the average decline of 52% and the fuma acid for nofove ester dipyridine tablets 96% of the decline, its advantages are self-evident, and in the "4 plus 7" expansion of the expansion of the price can not be used to win the bid, so the hydrochloric acid right Mitomi fixed injection not only procurement volume, but also to ensure profits, according to the conclusion of the first three sets of the largest winner is not YangziJiang.
Although the winning bid, but no sales, even if there is sales, sales are too low is not enough, because the value of the enterprise is measured first of all its revenue, not sales, and the company's job is to maximize profits.
So can get profit is the king, but the competition is so fierce, can win the bid has been good, that can also take into account so much, but the systematic analysis of the first three national selection results, I hope there are some inspiration and reference.
.